Literature DB >> 33231295

Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry.

Addi J Romero-Olmedo1, Axel R Schulz2, Magdalena Huber1, Corinna U Brehm3,4, Hyun-Dong Chang2, Cristina M Chiarolla5, Tobias Bopp6, Chrysanthi Skevaki7, Friederike Berberich-Siebelt5, Andreas Radbruch2, Henrik E Mei2, Michael Lohoff1.   

Abstract

CD56+ T cells are a group of pro-inflammatory CD3+ lymphocytes with characteristics of natural killer cells, being involved in antimicrobial immune defense. Here, we performed deep phenotypic profiling of CD3+ CD56+ cells in peripheral blood of normal human donors and individuals sensitized to birch-pollen or/and house dust mite by high-dimensional mass cytometry combined with manual and computational data analysis. A co-regulation between major conventional T-cell subsets and their respective CD3+ CD56+ cell counterparts appeared restricted to CD8+ , MAIT, and TCRγδ+ T-cell compartments. Interestingly, we find a co-regulation of several CD3+ CD56+ cell subsets in allergic but not in healthy individuals. Moreover, using FlowSOM, we distinguished a variety of CD56+ T-cell phenotypes demonstrating a hitherto underestimated heterogeneity among these cells. The novel CD3+ CD56+ subset description comprises phenotypes superimposed with naive, memory, type 1, 2, and 17 differentiation stages, in part represented by a phenotypical continuum. Frequencies of two out of 19 CD3+ CD56+ FlowSOM clusters were significantly diminished in allergic individuals, demonstrating less frequent presence of cells with cytolytic, presumably protective, capacity in these donors consistent with defective expansion or their recruitment to the affected tissue. Our results contribute to defining specific cell populations to be targeted during therapy for allergic conditions.
© 2020 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Entities:  

Keywords:  CD56; T cells; allergy; human; mass cytometry

Year:  2020        PMID: 33231295     DOI: 10.1002/eji.202048941

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma.

Authors:  Longxiang Tao; Shanshan Wang; Guijie Kang; Shanyue Jiang; Wenwei Yin; Lu Zong; Jing Li; Xuefu Wang
Journal:  Oncoimmunology       Date:  2021-11-09       Impact factor: 8.110

2.  Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy.

Authors:  Evelin A Leibinger; Gábor Pauler; Noémi Benedek; Tímea Berki; István Jankovics; Richard McNally; Gábor Ottóffy
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.